Aclaris Therapeutics ACRS
- ATI-2138 — Atopic Dermatitis Phase 2
- ATI-9494 Preclinical
- ATI-2138 — Lichen Planus Phase 2
ITK (2 companies · 5 programs)
Companies with an active program directed at ITK.
Corvus Pharmaceuticals, Inc. CRVS
- soquelitinib — Peripheral T Cell Lymphoma Phase 3
- soquelitinib — Atopic Dermatitis Phase 2